Showing results (141-150 of 162) with videos related to
Sort By:
Pageof 17
Cancer Research|April 15, 1994
Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridineW D Ensminger, S C Walker, P L Stetson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathwaysZ Ding, R E Parchment, P M LoRusso, et al.Cell Death and Differentiation|June 26, 2010
A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulumJ Lian, X Wu, F He, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 1993
Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant gliomaP W McLaughlin, W R Mancini, P L Stetson, et al.International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
The reproducibility of organ position using active breathing control (ABC) during liver radiotherapyL A Dawson, K K Brock, S Kazanjian, et al.Cancer Research|September 1, 1995
Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusionJ A Knol, S C Walker, J M Robertson, et al.Cancer Research|July 1, 1992
The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancerT S Lawrence, M A Davis, J Maybaum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapyJ M Robertson, T S Lawrence, L M Dworzanin, et al.Molecular Pharmacology|October 10, 1997
Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotypeL A Parsels, R C Zellars, T L Loney, et al.Oncogene|May 17, 2016
Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP poolsA Bianchi-Smiraglia, A Bagati, E E Fink, et al.Pageof 17